Location: Home
  • search
  • go
  • Relate News
  • 8/27/2021Chinese Patent Linkage, Patent Term Adjustment, and Patent Term Extens...
  • 8/26/2021BeyondSpring Announces Exclusive Deal with Jiangsu Hengrui Pharma for ...
  • 8/25/2021CDE Solicits Comments on the Technical Guidance for Human Bioavailabil...
  • 8/25/2021IQVIA: Chinese Hospital Drug Market Rose 14.2% in MAT Q2/2021
  • 8/25/2021NMPA and SASTIND Issue Notice for Improving Approval and Regulation of...
  • 8/25/2021China Penalizes NCPC for Failing to Fulfill VBP Supply Contracts
  • 8/25/2021Alphamab and CSPC Enter Licensing Deal on Anti-HER2 bsAntibody KN026 i...
  • 8/24/2021HebaBiz Biotech's Anti-cancer Candidate Siroquine Gains IND Approval i...
  • 8/24/2021NHC Solicits Comments on the Draft Working Procedures for Adjustment o...
  • 8/24/2021CDE Solicits Comments on the Technical Guidance for Food Impacts in Ne...
  • 8/24/2021CDE Solicits Comments on the Technical Guidance for Clinical Pharmacok...
  • 8/24/2021NMPA Announces Package Insert Revision of Oxaliplatin Formulations
  • 8/24/2021NMPA Announces Package Insert Revision of Propylthiouracil Formulation...
  • 8/24/2021Review of Top Ten Overseas Out-licensing Deals of Domestic Phama Compa...
  • 8/24/2021IQVIA: Overall Chinese Pharma Market Growth down 7.9% in 2020
  • 8/24/2021New Developments in China's Drug Change Management Regulations
  • 8/23/2021China Passes the Physicians Law of PRC to Protect Rights of Doctors
  • 8/23/2021Sino Biological Raises $772 Million in Shenzhen ChiNext IPO
  • 8/23/2021Antengene Approved fpr Phase II Study of Selinexor for Myelofibrosis i...
  • 8/23/2021BeiGene Announces Acceptance of a sBLA in China for Tislelizumab in Na...
  • 8/23/2021Roche and KeChow Partner to Commercialize Zelboraf (vemurafenib) in Ch...
  • 8/23/2021Lonza Expands Guangzhou Manufacturing Facility with a Fill-finish Line
  • 8/23/2021China Passes New Data Privacy and Security Laws
  • 8/23/2021BioDuro-Sundia Acquires US-based Phase III/Commercial Drug Product Man...
  • 8/22/2021Abogen Raises $700M in Series C Financing for mRNA Trials
  • 8/20/2021Novartis Receives Approval for Lucentis and Launches Galvus in China
  • 8/20/2021Recent Executive Moves
  • 8/19/2021Draft Plan for National Level VBP of Insulin Products under Comment Se...
  • 8/19/2021Adagene Announces the Third Clinical Trial Collaboration with Merck to...
  • 8/18/2021Innoforce Opens Cell and Gene Therapy Facility in Hangzhou
  • Page:201/803 Total number of articles:24071: [First][<<] [199] [200] [201] [202] [203] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group